Colossal Biosciences
About Colossal Biosciences
Colossal Biosciences is a genetics and biosciences company that aims to solve the problem of extinction through de-extinction, a functional application of advanced gene editing technology. The company is working to rebuild the DNA of lost megafauna and other creatures that had a measurably positive impact on fragile ecosystems. Colossal is led by CEO Ben Lamm and anchored by some of the most recognized names in science and industry.
Recent News
Hottest Deals In Tech Push Crunchbase Unicorn Board Toward $7T In Value
How a ‘TikTok Doctorate’ Made 26-Year-Old Griffin Johnson a Venture Capitalist
2026 Predictions: Historic FDA Shift, Plausible Mechanisms, Bespoke Tx, RFK Jr., Biotechs, State AGs, Peptides, Embryos
Colossal Biosciences Wins 2025 The Screamers Award for Science Hype on Dire Wolf De-Extinction Claim